Select a different bill



HB 0079 - Psuedoephedrine data in KASPER

Tracking Level: Support
Sponsor: L. Belcher
Last Action: 1/3/2012 - introduced in House; to Judiciary (H)
House Committee:
Assigned To:
Drugs and Substance AbuseNext Bill
KLC InitiativesNext Bill
Public SafetyNext Bill

Staff Analysis of the Legislation

HB 79 suspends until the end of the 2015 regular session the provisions of KRS 218A.1446 requiring pharmacists to dispense and maintain a written log of purchasers of pseudoephedrine. The bill instead classifies pseudoephedrine as a "legend drug" and requires data for each legend drug dispensed to be entered into the KASPER system. A practitioner cannot dispense more than 7.5 grams of pseudoephredrine to any user within a 30 day period. The provisions of HB 79 are effective until the end of the 2015 regular session when, apparently, the merits of the provisions will be reviewed and evaluated. HB 79 is similar to, but not the same as, SB 56 filed by Sen. Jensen. SB 56 repeals the provisions of KRS 218A.1446 requiring pharmacists to dispense and maintain a written log of purchasers of pseudoephedrine and permits data from KASPER to be shared with law enforcement officers.


Bill Summary from the State Site - Click for the State Summary Page / Click for Current Full Text
12RS HB79
LRC Seal

HB79

12RS

WWW Version

The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.


HB 79/LM/CI (BR 403) - L. Belcher, J. Bell, M. Marzian

     AN ACT relating to drugs.
     Amend KRS 217.015 to include drugs containing non-liquid ephedrine, pseudoephedrine, or phenylpropanolamine within the definition of a legend drug; amend KRS 217.182 to limit the amount of ephedrine-, pseudoephedrine-, or phenylpropanolamine-based legend drugs available within any one-month period and to exempt drug products obtained lawfully elsewhere within certain limits; amend KRS 218A.202 to include ephedrine-, pseudoephedrine-, or phenylpropanolamine-based legend drugs within the coverage of Kentucky's prescription monitoring system; sunset provisions on the effective date for legislation enacted by the 2015 General Assembly.

     (Prefiled by the sponsor(s).)

     Jan 3-introduced in House; to Judiciary (H)


Legislature Home Page | Record Front Page